Ginkgo Bioworks Holdings (DNA) Accounts Payables (2020 - 2025)

Ginkgo Bioworks Holdings filings provide 6 years of Accounts Payables readings, the most recent being $10.6 million for Q4 2025.

  • On a quarterly basis, Accounts Payables fell 25.43% to $10.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $10.6 million, a 25.43% decrease, with the full-year FY2025 number at $10.6 million, down 25.43% from a year prior.
  • Accounts Payables hit $10.6 million in Q4 2025 for Ginkgo Bioworks Holdings, down from $10.7 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $35.3 million in Q1 2022 to a low of $1.4 million in Q1 2021.
  • Median Accounts Payables over the past 5 years was $11.2 million (2025), compared with a mean of $13.8 million.
  • Biggest five-year swings in Accounts Payables: skyrocketed 2379.71% in 2022 and later plummeted 58.26% in 2025.
  • Ginkgo Bioworks Holdings' Accounts Payables stood at $8.2 million in 2021, then increased by 27.62% to $10.5 million in 2022, then fell by 10.79% to $9.3 million in 2023, then surged by 51.98% to $14.2 million in 2024, then decreased by 25.43% to $10.6 million in 2025.
  • The last three reported values for Accounts Payables were $10.6 million (Q4 2025), $10.7 million (Q3 2025), and $11.2 million (Q2 2025) per Business Quant data.